These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20187843)

  • 1. Prostatic diseases in the senescence: structural and proliferative features.
    Hetzl AC; Favaro WJ; Billis A; Ferreira U; Cagnon VH
    Aging Male; 2010 Jun; 13(2):124-32. PubMed ID: 20187843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal therapy in the senescence: Prostatic microenvironment structure and adhesion molecules.
    Montico F; Hetzl AC; Cândido EM; Fávaro WJ; Cagnon VH
    Micron; 2011 Aug; 42(6):642-55. PubMed ID: 21489806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-related changes in guinea pig prostatic stroma.
    Horsfall DJ; Mayne K; Ricciardelli C; Rao M; Skinner JM; Henderson DW; Marshall VR; Tilley WD
    Lab Invest; 1994 May; 70(5):753-63. PubMed ID: 8196369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model.
    Bonkhoff H; Remberger K
    Prostate; 1996 Feb; 28(2):98-106. PubMed ID: 8604398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroid hormone receptors, matrix metalloproteinases, insulin-like growth factor, and dystroglycans interactions in prostatic diseases in the elderly men.
    Hetzl AC; Fávaro WJ; Billis A; Ferreira U; Cagnon VH
    Microsc Res Tech; 2012 Sep; 75(9):1197-205. PubMed ID: 22648746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrastructural and proliferative features of the ventral lobe of the prostate in non-obese diabetic mice (NOD) following androgen and estrogen replacement associated to insulin therapy.
    Fávaro WJ; Padovani CR; Cagnon VH
    Tissue Cell; 2009 Apr; 41(2):119-32. PubMed ID: 19019401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A theoretical rationale on the histogenesis of premalignant lesions and early carcinoma of the prostate.
    Botticelli AR
    Pathologica; 1994 Apr; 86(2):128-41. PubMed ID: 7524011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostatic atrophy: an autopsy study of a histologic mimic of adenocarcinoma.
    Billis A
    Mod Pathol; 1998 Jan; 11(1):47-54. PubMed ID: 9556422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphometric and morphological features of the ventral prostate in rats submitted to chronic nicotine and alcohol treatment.
    Fávaro WJ; Cagnon VH
    Tissue Cell; 2006 Oct; 38(5):311-23. PubMed ID: 17014878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha 1-adrenoceptor antagonists terazosin and doxazosin induce prostate apoptosis without affecting cell proliferation in patients with benign prostatic hyperplasia.
    Chon JK; Borkowski A; Partin AW; Isaacs JT; Jacobs SC; Kyprianou N
    J Urol; 1999 Jun; 161(6):2002-8. PubMed ID: 10332490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ki-67 antigen and P53 protein expression in benign and malignant prostatic lesions. Immunohistochemical quantitative study.
    Sasor A; Wagrowska-Danilewicz M; Danilewicz M
    Pol J Pathol; 2000; 51(1):31-6. PubMed ID: 10833901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of AIbZIP and Cdc47 as markers for human prostatic diseases.
    Levesque MH; El-Alfy M; Berger L; Labrie F; Labrie C
    Urology; 2007 Jan; 69(1):196-201. PubMed ID: 17270658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferative activity in benign and neoplastic prostatic epithelium.
    Limas C; Frizelle SP
    J Pathol; 1994 Nov; 174(3):201-8. PubMed ID: 7823253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of normal stromal components and their correlation with cancer occurrence in human prostate.
    Zhang Y; Nojima S; Nakayama H; Jin Y; Enza H
    Oncol Rep; 2003; 10(1):207-11. PubMed ID: 12469170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Proliferation and apoptosis of epithelium in prostate cancer, in a peritumor region, and in benign hyperplasia].
    Fedosenko KV; Koval'skiĭ GB
    Arkh Patol; 2003; 65(3):18-20. PubMed ID: 12879605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
    Man YG; Gardner WA
    Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of the nuclear proliferative index (Ki-67) in benign prostate, prostatic intraepithelial neoplasia, and prostatic carcinoma.
    Tamboli P; Amin MB; Schultz DS; Linden MD; Kubus J
    Mod Pathol; 1996 Oct; 9(10):1015-9. PubMed ID: 8902840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between atypical adenomatous hyperplasia (AAH), prostatic intraepithelial neoplasia (PIN) and prostatic adenocarcinoma.
    Helpap B; Bonkhoff H; Cockett A; Montironi R; Troncoso P; Waters D; Bostwick D
    Pathologica; 1997 Jun; 89(3):288-300. PubMed ID: 9270265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.